| 000 | 01826 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517024135.0 | ||
| 264 | 0 | _c20150728 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1365-2168 | ||
| 024 | 7 |
_a10.1002/bjs.9775 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShimoda, M | |
| 245 | 0 | 0 |
_aRandomized clinical trial of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection. _h[electronic resource] |
| 260 |
_bThe British journal of surgery _cJun 2015 |
||
| 300 |
_a746-54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxonic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aPancreatectomy |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPostoperative Care _xmethods |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 650 | 0 | 4 |
_aTegafur _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aKubota, K | |
| 700 | 1 | _aShimizu, T | |
| 700 | 1 | _aKatoh, M | |
| 773 | 0 |
_tThe British journal of surgery _gvol. 102 _gno. 7 _gp. 746-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/bjs.9775 _zAvailable from publisher's website |
| 999 |
_c24765650 _d24765650 |
||